Upload Avatar (500 x 500)
Xuming Deng
dengxm@jlu.edu.cn
Chinese, English
Jilin
Jilin University
Veterinary Medicine
  • 1994-1998: PhD in Preventive Veterinary Medicine, PLA Agricultural and Pastoral University
  • 1984-1987: Master's in Veterinary Pharmacology and Toxicology, PLA Veterinary University
  • 1980-1984: Bachelor's in Veterinary Medicine, Hunan Agricultural University
  • 2014-present: Jilin University, College of Veterinary Medicine, Tang Aoqing Distinguished Professor, PhD Supervisor
  • 2004-2014: Jilin University, College of Animal Science and Veterinary Medicine, Professor, PhD Supervisor
  • 2002-2004: PLA Logistics University, Department of Veterinary Pharmacology, Professor
  • 1997-2002: PLA Logistics University, Department of Veterinary Pharmacology, Associate Professor
  • 1987-1997: PLA Veterinary University, Department of Veterinary Pharmacology, Lecturer
  • 2015: Second Prize, Excellent Scientific Research Achievement Award of Higher Education (Science and Technology) for the study on the mechanism of action and key targets of traditional Chinese medicine components against resistant Staphylococcus aureus
  • 2020: Second Prize, Jilin Province Science and Technology Award for the study on the effect of traditional Chinese medicine monomers on inflammatory diseases and their molecular mechanisms
Veterinary Pharmacology and Toxicology
  • Amentoflavone attenuates Listeria monocytogenes pathogenicity through an LLO-dependent mechanism, Tingting W, Tianqi F, Xinyu W, Can Z, Xue S, Xuming D, Jianfeng W, 2022
  • Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases, Liu S, Zhang J, Zhou Y, Hu N, Li J, Wang Y, Niu X, Deng X, Wang J, 2019
  • Pterostilbene, a Potential MCR-1 Inhibitor That Enhances the Efficacy of Polymyxin B, Zhou Y, Liu S, Wang T, Li H, Tang S, Wang J, Wang Y, Deng X, 2018
  • NMPA-approved traditional Chinese medicine-Pingwei Pill: new indication for colistin recovery against MCR-positive bacteria infection, Sheng Q, Du R, Ma C, Zhou Y, Shen X, Hou X, Xu L, Li L, Deng X, Wang J, 2021
  • Discovery of a potential MCR-1 inhibitor that reverses polymyxin activity against clinical mcr-1-positive Enterobacteriaceae, Zhou Y, Wang J, Guo Y, Liu X, Liu S, Niu X, Wang Y, Deng X, 2019
Veterinary Pharmacology Toxicology Drug Resistance Antibacterial Therapy Mechanisms Molecular Biology Pathogens Inhibitors

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.